Quebec announces intention to implement a biosimilar switching policy

Biosimilars Canada

18 May 2021 - Biosimilars Canada today congratulated the Government of Quebec and Minister of Health and Social Services Christian Dubé for announcing the province's intention to implement a biosimilar switching policy under its public prescription drug insurance plan.

The expanded use of biosimilars in Quebec is expected to generate annual savings of $100 million as of 2022.

Read Biosimilars Canada press release

Michael Wonder

Posted by:

Michael Wonder